Sulindac sulfide as a non-immune suppressive gamma secretase modifier to target triple negative breast cancer

Authors

Fokhrul Hossain, LSU Health Sciences Center - New OrleansFollow
Deniz A. Ucar, LSU Health Sciences Center - New Orleans
Samarpan Majumder, LSU Health Sciences Center - New OrleansFollow
Margarite Matossian, Tulane University
Giulia Monticone, LSU Health Sciences Center - New OrleansFollow
Keli Xu, University of Mississippi Medical Center
Yong Ran, University of Florida
Lisa Minter, UMass Amherst
Yaguang Xi, LSU Health Sciences Center - New OrleansFollow
Matthew Burow, Tulane University
Todd Golde, University of Florida
Barbara Osborne, UMass Amherst
Lucio Miele, LSU Health Sciences Center - New OrleansFollow

Document Type

Article

Publication Date

2-15-2020

Publication Title

Cancer research

Volume

80(4 Suppl)

Comments

Abstract Number: P5-04-19

Recommended Citation

Hossain, Fokhrul; Ucar, Deniz A.; Majumder, Samarpan; Matossian, Margarite; Monticone, Giulia; Xu, Keli; Ran, Yong; Minter, Lisa; Xi, Yaguang; Burow, Matthew; Golde, Todd; Osborne, Barbara; and Miele, Lucio, "Sulindac sulfide as a non-immune suppressive gamma secretase modifier to target triple negative breast cancer" (2020). School of Graduate Studies Faculty Publications. 194.
https://digitalscholar.lsuhsc.edu/sogs_facpubs/194